Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:


Treating Tardive Dyskinesia: Clinical Challenges and Patient Perspectives

Access Activity

Overview / Abstract:

This Clinical Commentary consists of an HD video roundtable discussion with two leading expert psychiatrists in the field, who participate in a panel discussion of tardive dyskinesia (TD) as a widespread and undertreated condition in psychiatric populations, as well as the importance of evidence-based differential diagnostics, newly approved therapeutics for treatment of the condition, and strategies for both personalized and improved patient care. This activity additionally includes an interview with a leading neurologist who reviews diagnostic algorithms for TD and shares her perspective on the impact of new drug approvals and strategies for working together with psychiatrists in managing patients with TD. Throughout the activity, testimonials of a patient with tardive dyskinesia are incorporated to bring relevance to the patient perspective, experience and treatment goals.

Tardive dyskinesia (TD) is a medication-induced, disabling, and often-permanent neurological, hyperkinetic movement-disorder syndrome. TD has significant impact on patients’ activities of daily living (ADLs) and overall quality of life. Physicians require education and awareness on diagnostic algorithms for TD, on agents newly approved for its treatment, and on the associated risks/benefits of those agents’ use in the TD population based on the most recent clinical data and evidence.

Upon completion of this activity, participants will be able to:
• Evaluate possible clinical indication(s) and patient population(s) that may be at increased risk for tardive dyskinesia (TD).
• Discuss the role of dopamine antagonists and/or other therapies that may play a role in the pathophysiology of TD.
• Recognize the risks, benefits, and possible complications associated with managing TD in the psychiatric population.
• Describe the importance of differential diagnosis and current evidence-based treatment paradigms for patients at risk for TD.
• Interpret the clinical trial efficacy and safety data of novel and emerging therapies for TD.


Aug 31, 2019


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Psychology CE, Social Work CE


Online, Webinar / Webcast / Video

Credits / Hours




Is This Activity Certified for "Live" Credit?


Presenters / Authors / Faculty

Cynthia Comella, MD
Professor, Department of Neurological Sciences
Section of Parkinson’s Disease and Movement Disorders
Rush University Medical Center
Chicago, IL

Christoph Correll, MD
Professor, Center for Psychiatric Neuroscience,
The Feinstein Institute for Medical Research
Professor, Psychiatry and Molecular Medicine,
Hofstra Northwell School of Medicine
Medical Director, Recognition and Prevention,
Department of Psychiatry,
The Zucker Hillside Hospital
New York, NY

John Kane, MD
Professor & Chairman,
Psychiatry, Neurology and Neurosciences
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Chairman, Department of Psychiatry
The Zucker Hillside Hospital
New York, NY

Activity Specialities / Related Topics

Adverse Drug Reactions / ADR, Behavioral Medicine, Depression / Bipolar, Education / Teaching, Family Medicine, Internal Medicine, Language Disorders / Aphasia, Neurology, Psychiatry / Mental Health, Speech Language Pathology

Sponsors / Supporters / Grant Providers

Sponsored by the Academy for Continued Healthcare Learning (ACHL).

Supported by an educational grant from Neurocrine BioSciences.

Keywords / Search Terms

ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Webcasts, Newsletter, Case Study, Live Meetings, Slidekit, Monograph, Journal, Tardive dyskinesia, TD, Dyskinesia, psychiatry, neurology, dopamine antagonist, Dopamine Receptor-Blocking Agents, antipsychotics, KINECT 4, INGREZZA, valbenazine, deutetrabenazine, Neurocrine Biosciences, Neurocrine, Christoph Correll, Correll, Comella, Cynthia Comella Free CE CME Live CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.